These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 19299149)

  • 21. Nanotechnological applications for the treatment of neurodegenerative disorders.
    Modi G; Pillay V; Choonara YE; Ndesendo VM; du Toit LC; Naidoo D
    Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemical modification of therapeutic drugs or drug vector systems to achieve targeted therapy: looking for the grail.
    Juillerat-Jeanneret L; Schmitt F
    Med Res Rev; 2007 Jul; 27(4):574-90. PubMed ID: 17022028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The nanoscale in pulmonary delivery. Part 2: formulation platforms.
    Rogueda PG; Traini D
    Expert Opin Drug Deliv; 2007 Nov; 4(6):607-20. PubMed ID: 17970664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A; Stolnik S; Illum L
    Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted ultrasound-mediated delivery of nanoparticles: on the development of a new HIFU-based therapy and imaging device.
    Seip R; Chin CT; Hall CS; Raju BI; Ghanem A; Tiemann K
    IEEE Trans Biomed Eng; 2010 Jan; 57(1):61-70. PubMed ID: 19695986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expansile nanoparticles: synthesis, characterization, and in vivo efficacy of an acid-responsive polymeric drug delivery system.
    Griset AP; Walpole J; Liu R; Gaffey A; Colson YL; Grinstaff MW
    J Am Chem Soc; 2009 Feb; 131(7):2469-71. PubMed ID: 19182897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyaluronate-covered nanoparticles for the therapeutic targeting of cartilage.
    Laroui H; Grossin L; Léonard M; Stoltz JF; Gillet P; Netter P; Dellacherie E
    Biomacromolecules; 2007 Dec; 8(12):3879-85. PubMed ID: 18039001
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solid lipid nanoparticles for targeted brain drug delivery.
    Blasi P; Giovagnoli S; Schoubben A; Ricci M; Rossi C
    Adv Drug Deliv Rev; 2007 Jul; 59(6):454-77. PubMed ID: 17570559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chitosan nanoparticles as a new delivery system for the chemotherapy agent tegafur.
    Arias JL; López-Viota M; Gallardo V; Adolfina Ruiz M
    Drug Dev Ind Pharm; 2010 Jun; 36(6):744-50. PubMed ID: 20345283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential of solid lipid nanoparticles in brain targeting.
    Kaur IP; Bhandari R; Bhandari S; Kakkar V
    J Control Release; 2008 Apr; 127(2):97-109. PubMed ID: 18313785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.
    Torchilin VP
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):548-58. PubMed ID: 18053612
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential neurotoxicity of nanoparticles.
    Hu YL; Gao JQ
    Int J Pharm; 2010 Jul; 394(1-2):115-21. PubMed ID: 20433914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiparticulate formulation approach to colon specific drug delivery: current perspectives.
    Asghar LF; Chandran S
    J Pharm Pharm Sci; 2006; 9(3):327-38. PubMed ID: 17207416
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery.
    Mandal BB; Kundu SC
    Nanotechnology; 2009 Sep; 20(35):355101. PubMed ID: 19671963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous intracellular delivery of targeting antibodies and functional nanoparticles with engineered protein G system.
    Lim YT; Cho MY; Lee JM; Chung SJ; Chung BH
    Biomaterials; 2009 Feb; 30(6):1197-204. PubMed ID: 19056121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted charge-reversal nanoparticles for nuclear drug delivery.
    Xu P; Van Kirk EA; Zhan Y; Murdoch WJ; Radosz M; Shen Y
    Angew Chem Int Ed Engl; 2007; 46(26):4999-5002. PubMed ID: 17526044
    [No Abstract]   [Full Text] [Related]  

  • 37. Physical and chemical stability of drug nanoparticles.
    Wu L; Zhang J; Watanabe W
    Adv Drug Deliv Rev; 2011 May; 63(6):456-69. PubMed ID: 21315781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?
    Costantino L; Boraschi D
    Drug Discov Today; 2012 Apr; 17(7-8):367-78. PubMed ID: 22094246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanoparticles for intracellular-targeted drug delivery.
    Paulo CS; Pires das Neves R; Ferreira LS
    Nanotechnology; 2011 Dec; 22(49):494002. PubMed ID: 22101232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prediction of convection-enhanced drug delivery to the human brain.
    Linninger AA; Somayaji MR; Mekarski M; Zhang L
    J Theor Biol; 2008 Jan; 250(1):125-38. PubMed ID: 17950757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.